BioAgilytix Welcomes Lydia Michaut, Ph.D. to Team as Scientific Officer

Dr. Michaut Brings More than 25 Years of Experience in Fundamental Research and Clinical Development, Including Work in Two Award-Winning Academic Laboratories

FEBRUARY 7, 2019—Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has welcomed Lydia Michaut, Ph.D. to its team as Scientific Officer. Dr. Michaut will be based in BioAgilytix Europe’s laboratory in Hamburg, Germany and will play an integral role in the oversight of its bioanalytical teams as well as project strategies.

Dr. Michaut brings with her 15 years of fundamental research experience contributing important work in two cutting-edge academic laboratories, both of which were recognized with prestigious scientific prizes including the 2002 Balzan Prize and the 2011 Nobel Prize. Following her time in academia, Dr. Michaut spent 10 years at Novartis in Basel, Switzerland where she was involved in the clinical development and approval of biological protein drugs across multiple therapeutic areas. She was most recently Senior Investigator in PK Sciences and supported advanced medicinal products including gene therapies. A key part of her role also included interfacing with Health Authority agencies to align project teams and bioanalytical strategies with regulatory guideline requirements.

“Lydia’s dual expertise in fundamental research and regulated drug development is unique and will certainly be of benefit to our customers,” said PD Dr. Arno Kromminga, Global Chief Scientific Officer of BioAgilytix. “She is esteemed in the industry and regarded as an expert in assessments for biologics and gene therapy products, as well as in the best practices for upholding compliance with current regulatory requirements.”

“I am thrilled to join BioAgilytix and for the opportunity to work closely with Arno and the entire BioAgilytix team,” said Dr. Michaut. “BioAgilytix’s track record in the realm of large molecules is unmatched and I look forward to helping them continue to build upon that reputation with premier regulated bio-analytics supporting innovative new drugs, particularly in the area of gene and cell therapy.”


About BioAgilytix

BioAgilytix is a leading bioanalytical testing laboratory specializing in large molecule bioanalysis. With laboratory locations in North Carolina’s Research Triangle area and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of biologics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, GLP, and GCP, as well as GMP quality control testing (i.e. product release testing, stability testing, etc.).

BioAgilytix’s team of highly experienced scientific and QA professionals ensures high quality science, data integrity, and regulatory compliance through all phases of clinical development, and is a trusted partner to many of the top global pharmaceutical and biotech companies. For more information, visit

Media Contact:
Carla Nieser
Vovéo Marketing Group
610.240.0400, x 118

Share This